News search
Research 5 Jan 2022 Scientists at the CNIC have developed a simple model for studying the behavior of immune cells in live animals and have identified a harmful cell behavior pattern associated with cardiovascular disease |
Research 18 Nov 2021 Immune therapy based on nasal administration of a preparation of dead bacteria called MV130 prevents death in experimental animals infected with the SARS-CoV-2 coronavirus and increases the immunogenicity of COVID-19 vaccines |
Research 12 Nov 2021 A study published in Science Advances shows that the gene GPR126, while not required for the development of the heart, plays an essential role in the formation of the placenta, the gestational organ that nourishes the fetus |
Research 26 Oct 2021 Scientists from the CNIC and the CIBERCV have generated the first experimental animal model that develops Hutchinson-Gilford Progeria Syndrome and allows its controlled reversal |
Research 18 Oct 2021 Researchers from the National Center for Cardiovascular Research and the Pompeu Fabra University describe in Science a new mechanism for muscle regeneration after physiological damage |
Research 28 Sep 2021 This innovative technology may provide an efficient approach in clinical practice after manual or automatic segmentation of myocardial borders in a small number of conventional 2D slices and automatic scar detection |
About the CNIC 6 Aug 2021 CNIC and the Mario Negri Institute in Milan (Italy) coordinate REBOOT, a project that aims to study whether treatment with beta-blockers is beneficial for patients who have suffered a myocardial infarction |
About the CNIC 6 Jul 2021 This project represents a major development in the need to implement early cardiovascular intervention strategies that are capable of reducing the incidence of AD at the advanced ages in Alzheimer's disease |
Research 29 Jun 2021 A study published in JACC shows that excess circulating triglyceride concentrations are associated with subclinical atherosclerosis and vascular inflammation in individuals with low-to-moderate cardiovascular risk according to standard scores |
About the CNIC 29 Jun 2021 Over one million European cancer patients suffer from side effects to chemotherapy |
- ‹ previous
- 8 of 29
- next ›